Teva Pharmaeuticals Ireland, formerly known as Ivax Pharmaceuticals, is one of Ireland’s longest established and leading pharmaceutical companies. Our state–of–the–art Waterford facility, currently under expansion, combines production of a significant portfolio of solid dose products for the US market, with the production of inhalations devices for global markets. A leading–edge Research and Development unit on site is charged with the development of next–generation inhalations devices for the treatment of asthma, COPD and other respiratory conditions. Our market–leading portfolio of products includes the Easi–Breathe® inhaler which has revolutionised the treatment of asthma and is fast becoming the breath–activated device of choice for asthmatics worldwide.

Headquartered in the thriving, historic port city of Waterford, Teva employs more than 700 people in three plants.